Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (cx43)

Cancer Research

Volumn 58, Issue 22, 1998, Pages 5089-5096

  Huang, Ruo Pan ^a   Fan, Yan ^a   Hossain, Mohammad Z ^a   Peng, Ao ^a   Zeng, Zi Li ^a,b   Boynton, Alton L ^a  

^a NORTHWEST HOSPITAL   (United States)

^b SHANTOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 43;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; GAP JUNCTION; GLIOBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT;

ANIMALS; BRAIN NEOPLASMS; CELL COMMUNICATION; CELL DIVISION; CONNEXIN 43; GAP JUNCTIONS; GENES, TUMOR SUPPRESSOR; GLIOBLASTOMA; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; PHENOTYPE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032533831     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Yamasaki, H., and Naus, C. C. G. Role of connexin genes in growth control. Carcinogenesis (Lond.), 17: 1199-1213, 1996.
2. Lau, A. F., Kanemitsu, M. Y., Kurata, W. E., Danesh, S., and Boynton, A. L. Epidermal growth factor disrupts gap-junctional communication and induces phosphorylation of connexin43 on serine. Mol. Biol. Cell, 3: 865-874, 1992.
3. Schmidt, J. N., Traenckner, E. B., Meier, B., and Baeuerle, P. A. Induction of oxidative stress by okadaic acid is required for activation of transcription factor NF-κ B. J. Biol. Chem., 270: 27136-27142, 1995.
4. Zhu, D., Caveney, S., Kidder, G. M., and Naus, C. C. Transfection of C6 glioma cells with connexin 43 cDNA: analysis of expression, intercellular coupling, and cell proliferation. Proc. Natl. Acad. Sci. USA, 88: 1883-1887, 1991.
5. Naus, C. C., Elisevich, K., Zhou, D., Beliveau, D. J., and Del Maestro, R. F. In vivo growth of C6 glioma cells transfected with connexin43 cDNA. Cancer Res., 52: 4208-4213, 1992.
6. Hirschi, K. K., Xu, C. E., Tsukamoto, T., and Sager, R. Gap junction gene cx26 and cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. Cell Growth Differ., 7: 861-870, 1996.
7. Eghbali, B., Kessler, J. A., Reid, L. M., Roy, C., and Spray, D. C. Involvement of gap junctions in tumorigenesis: transfection of tumor cells with cx32 cDNA retards growth in vivo. Proc. Natl. Acad. Sci. USA, 88: 10701-10705, 1991.
8. Chen, S-C., Pelletier, D. B., Ao, P., and Boynton, A. L. Connexin43 reverses the phenotype of transformed cells and alters their expression of cyclin/cyclin-dependent kinases. Cell Growth Differ., 6: 681-690, 1995.
9. Proulx, A. A., Lin, Z-X., and Naus, C. C. G. Transfection of rhabdomyosarcoma cells with connexin43 induced myogenic differentiation. Cell Growth Differ., 8: 533-540, 1997.
10. Zhu, W-B., Mironov, N., and Yamasaki, H. Increased genetic stability of HeLa cells after connexin 43 gene transfection. Cancer Res., 57: 2148-2150, 1997.
11. Kenney, N. J., Huang, R-P., Johnson, G., Wu, J. X., Okamura, D., Metheny, W., Gordon, E., Gulick, W., Plowman, G., Smith, G. H., Salomon, D. S., and Adamson, E. D. Expression of amphiregulin (AR) and cripto (CR-1) in the developing murine mammary gland. Mol. Reprod. Dev., 41: 277-286, 1995.
12. Huang, R. P., Wu, J. X., Fan, Y., and Adamson, E. D. UV activates growth factor receptors via reactive oxygen intermediates. J. Cell Biol., 133: 211-220, 1996.
13. Huang, R. P., Fan, Y., De Belle, I., Niemeyer, C., Gottardis, M. M., Mercola, D., and Adamson, E. D. Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Int. J. Cancer, 72: 102-109, 1997.
14. Huang, R. P., Fan, Y., deBelle, I. Ni, Z., Matheny, W., and Adamson, E. D. Egr-1 inhibits apoptosis during the UV response: correlation of cell survival with Egr-1 phosphorylation. Cell Death Differ., 5; 96-106, 1998.
15. Huang, R. P., Liu, C., Fan, Y., Mercola, D., and Adamson, E. D. Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain. Cancer Res., 55: 5054-5062, 1995.
16. Huang, R. P., Darland, T., Okamura, D., Mercola, D., and Adamson, E. D. Suppression of v-sis-dependent transformation by the transcription factor, Egr-1. Oncogene, 9: 1367-1377, 1994.
17. Huang, R. P., Ngo, L., Okamura, D., Tucker, M., and Adamson, E. D. V-sis induces Egr-1 expression by a pathway mediated by c-Ha-Ras. J. Cell. Biochem., 56: 469-479, 1994.
18. Tsai, H., Werber, L., Davia, M. O., Edelman, M., Tanaka, K. E., Melman, A., Christ, G. J., and Gelieber, J. Reduced connexin43 expression in high grade, human prostatic adenocarcinoma cells. Biochem. Biophys. Res. Commun., 227: 64-69, 1996.
19. Wilgenbus, K. K., Kirkpatrick, C. J., Knuechel, R., and Traub, O. Expression of cx26, cx32 and cx43 gap junction proteins in normal and neoplastic human tissues. Int. J. Cancer, 51: 522-529, 1992.
20. Lee, S-W., Paul, D. L., Keyomarsi, K., and Sager, R. Transcriptional down-regulation of gap junction proteins blocks junctional communication in human mammary tumor cell lines. J. Cell Biol., 118: 1213-1221, 1992.
21. Tomasetto, C., Neveu, M. J., Daley, J., Horan, P. K., and Sager, R. Specificity of gap junction communication among human mammary cells and connexin transfections in culture. J. Cell Biol., 122: 157-167, 1993.
22. Grossman, H. B., Lieben, M., Lee, I. W., and Lee, S. W. Decreased connexin expression and intercellular communication in human bladder cancer cells. Cancer Res., 54: 3062-3065, 1994.
23. Tsuda, H., Asamoto, M., Baba, H., Iwahori, Y., Matsumoto, K., Iwase, T., Nishida, Y., Nagao, S., Hakoi, K., and Yamaguchi, S. E. Cell proliferation and advancement of hepatocarcinogenesis in the rat associated with a decrease in connexin 32 expression. Carcinogenesis (Lond.), 16: 101-105, 1995.
24. Finlay, C. A., Hinds, P. W., and Levine, A. J. The p53 protooncogene can act as a suppressor of transformation. Cell, 57: 1083-1093, 1989.
25. Call, K. M., Glaser, T., Ito, C. Y., Buckler, A. J., Pelletier, J., Haber, D. A., Rose, E. A., Krai, A., Yeger, H., Lewis, W. H., Jones, C., and Housman, D. E. Isolation and characterization of a Zinc finger polypeptide gene at the human chromosome 11 Wilm's tumor locus. Cell, 60: 509-520, 1990.
26. Miki, Y. E. a strong candidate for the breast and ovarian cancer susceptibility gene BRCAI. Science (Washington DC), 266: 66-69, 1994.
27. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q-Y., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., III, Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.
28. Zou, A., Anisowicz, A., Hendrix, M. J., Thor, A., Neveu, M., Sheng, S., Rafidi, K., Seftor, E., and Sager, R. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science (Washington DC), 263: 526-529, 1994.
29. Sager, R., Anisowicz, A., Neveu, M., Liang, F., and Sotiropoulou, G. Identification by differential display of α6 integrin as a candidate tumor suppressor gene. FASEB J., 7: 964-970, 1993.
30. Musil, L. S., Cunningham, B. A., Edelman, G. M., and Goodenough, D. A. Differential phosphorylation of the gap junction protein cx43 in junctional communication-competent and -deficient cell lines. J. Cell Biol., 111: 2077-2088, 1990.
31. Wang, Y., Metha, P. P., and Rose, B. Inhibition of glycosylation induces open connexin43 cell-cell channels and phosphorylation and Triton X-100 insolubility of connexin43. J. Biol. Chem. 270: 26581-26585, 1995.
32. de Feijiter, A. W., Matesic, D. F., Ruch, R. J., Guan, X. J., Chang, C. C., and Trosko, J. E. Localization and function of the connexin 43 gap-junction protein in normal and various oncogene-expressing rat liver epithelial cells. Mol. Carcinog., 16: 203-212, 1996.
33. Martyn, K. D., Kurata, W. E., Warn-Cramer, B. J., Butt, J. M., TenBroek, E., and Lau, A. F. Immortalized connexin43 knockout cell lines display a subset of biological properties associated with the transformed phenotype. Cell Growth Differ., 8: 1015-1027, 1997.
34. Duflot-Dancer, A., Mesnil, M., and Yamasaki, H. Dominant-negative abrogation of connexin-mediated cell growth control by mutant connexin genes. Oncogene, 15: 2151-2158, 1997.